Showing results (71-80 of 137) with videos related to
Sort By:
Pageof 14
Japanese Journal of Clinical Oncology|May 19, 2015
A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancerYujiro Ueda, Nobuaki Matsubara, Itsuhiro Takizawa, et al.BMC Research Notes|October 21, 2016
Abiraterone acetate after progression with enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysisYoko Yamada, Nobuaki Matsubara, Ken-Ichi Tabata, et al.International Journal of Molecular Sciences|January 14, 2017
Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate CancerHideyasu Tsumura, Takefumi Satoh, Hiromichi Ishiyama, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|April 8, 2010
Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsyMakoto Ohori, Michael W Kattan, Changhong Yu, et al.Current Oncology (Toronto, Ont.)|May 26, 2023
Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 PatientsKyohei Fujii, Masahiro Nakano, Shogo Kawakami, et al.Cancer|June 2, 2009
Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinomaTakefumi Satoh, Masaki Kimura, Kazumasa Matsumoto, et al.Journal of Contemporary Brachytherapy|March 18, 2016
Dosimetry of permanent interstitial prostate brachytherapy for an interoperative procedure, using O-arm based CT and TRUSHiromichi Ishiyama, Akane Sekiguchi, Takefumi Satoh, et al.BMJ Open|August 17, 2021
Unmet needs in non-metastatic castration-resistant prostate cancer from the Japanese patient perspective: a discrete choice experimentHiroji Uemura, Hisashi Matsushima, Akira Yokomizo, et al.BJU International|December 21, 2010
A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatinKazumasa Matsumoto, Masanori Noguchi, Takefumi Satoh, et al.Urology|July 5, 2005
Cancer core distribution in patients diagnosed by extended transperineal prostate biopsyTakefumi Satoh, Kazumasa Matsumoto, Tetsuo Fujita, et al.Pageof 14